BSX – Boston Scientific Corporation
BSX — Price & Forward EBITDA
Forward EBITDA (M)
Float Short %
1.72
Margin Of Safety %
17
Put/Call OI Ratio
0.4
EPS Next Q Diff
0.07
EPS Last/This Y
0.41
EPS This/Next Y
0.44
Price
69.19
Target Price
101.52
Analyst Recom
1.24
Performance Q
-28.02
Upside
-38.3%
Beta
0.73
Ticker: BSX
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-03-02 | BSX | 76.21 | 0.46 | 0.75 | 383813 |
| 2026-03-04 | BSX | 72.18 | 0.45 | 0.09 | 394555 |
| 2026-03-05 | BSX | 72.99 | 0.42 | 1.98 | 418846 |
| 2026-03-09 | BSX | 71.77 | 0.43 | 3.71 | 403286 |
| 2026-03-10 | BSX | 69.95 | 0.44 | 0.16 | 410247 |
| 2026-03-11 | BSX | 69.63 | 0.42 | 0.25 | 415485 |
| 2026-03-12 | BSX | 68.54 | 0.42 | 1.73 | 423174 |
| 2026-03-17 | BSX | 71.23 | 0.42 | 0.32 | 414662 |
| 2026-03-18 | BSX | 71.28 | 0.41 | 0.25 | 420058 |
| 2026-03-19 | BSX | 69.91 | 0.41 | 3.30 | 429835 |
| 2026-03-20 | BSX | 69.52 | 0.43 | 0.41 | 439221 |
| 2026-03-23 | BSX | 69.53 | 0.41 | 0.19 | 358585 |
| 2026-03-24 | BSX | 68.15 | 0.40 | 0.91 | 372787 |
| 2026-03-25 | BSX | 69.78 | 0.39 | 0.16 | 376265 |
| 2026-03-26 | BSX | 70.19 | 0.39 | 0.88 | 384960 |
| 2026-03-27 | BSX | 69.19 | 0.40 | 0.30 | 400114 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-02-27 | BSX | 76.85 | 5.8 | 1432.6 | 3.46 |
| 2026-03-02 | BSX | 76.21 | 5.8 | 2569.5 | 3.46 |
| 2026-03-03 | BSX | 73.85 | 5.8 | 2435.3 | 3.46 |
| 2026-03-04 | BSX | 72.19 | 5.8 | 2486.5 | 3.46 |
| 2026-03-05 | BSX | 72.98 | 5.8 | 2680.2 | 3.46 |
| 2026-03-06 | BSX | 71.29 | 5.8 | 2482.8 | 3.46 |
| 2026-03-09 | BSX | 71.90 | 5.7 | 2663.4 | 3.47 |
| 2026-03-10 | BSX | 69.95 | 5.7 | 2459.8 | 3.47 |
| 2026-03-11 | BSX | 69.62 | 5.7 | 2589.7 | 3.47 |
| 2026-03-12 | BSX | 68.54 | 5.7 | 2526.9 | 3.47 |
| 2026-03-13 | BSX | 69.12 | 5.6 | 2666.7 | 3.47 |
| 2026-03-17 | BSX | 71.21 | 5.6 | 2736.4 | 3.47 |
| 2026-03-18 | BSX | 71.29 | 5.6 | 2624.9 | 3.47 |
| 2026-03-19 | BSX | 69.90 | 5.6 | 1508.0 | 3.47 |
| 2026-03-20 | BSX | 69.52 | 5.6 | 1576.6 | 3.47 |
| 2026-03-23 | BSX | 69.54 | 5.6 | 1606.4 | 3.47 |
| 2026-03-24 | BSX | 68.15 | 5.6 | 1504.8 | 3.47 |
| 2026-03-25 | BSX | 69.77 | 5.6 | 1718.5 | 3.47 |
| 2026-03-26 | BSX | 70.18 | 5.6 | 1629.5 | 3.47 |
| 2026-03-27 | BSX | 69.19 | 5.6 | 1533.1 | 3.47 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-02-27 | BSX | -5.91 | -0.73 | 1.80 |
| 2026-03-02 | BSX | -5.91 | 0.10 | 1.80 |
| 2026-03-03 | BSX | -6.06 | 0.10 | 1.80 |
| 2026-03-04 | BSX | -5.25 | 0.10 | 1.80 |
| 2026-03-05 | BSX | -5.25 | 0.10 | 1.80 |
| 2026-03-06 | BSX | -5.25 | 0.10 | 1.80 |
| 2026-03-09 | BSX | -5.25 | 0.10 | 1.80 |
| 2026-03-10 | BSX | -5.25 | 0.10 | 1.80 |
| 2026-03-11 | BSX | -5.25 | 0.10 | 1.78 |
| 2026-03-12 | BSX | -5.25 | 0.10 | 1.78 |
| 2026-03-13 | BSX | -5.25 | 0.10 | 1.78 |
| 2026-03-17 | BSX | -5.24 | 0.38 | 1.78 |
| 2026-03-18 | BSX | -5.25 | 0.38 | 1.78 |
| 2026-03-19 | BSX | -5.25 | 0.38 | 1.78 |
| 2026-03-20 | BSX | -5.25 | 0.38 | 1.78 |
| 2026-03-23 | BSX | -5.25 | 0.25 | 1.78 |
| 2026-03-24 | BSX | -5.25 | 0.25 | 1.78 |
| 2026-03-25 | BSX | -5.25 | 0.25 | 1.72 |
| 2026-03-26 | BSX | -5.25 | 0.25 | 1.72 |
| 2026-03-27 | BSX | -5.25 | 0.25 | 1.72 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.8
Avg. EPS Est. Current Quarter
0.79
Avg. EPS Est. Next Quarter
0.87
Insider Transactions
-5.25
Institutional Transactions
0.25
Beta
0.73
Average Sales Estimate Current Quarter
5186
Average Sales Estimate Next Quarter
5562
Fair Value
81.13
Quality Score
90
Growth Score
97
Sentiment Score
53
Actual DrawDown %
36.8
Max Drawdown 5-Year %
-37
Target Price
101.52
P/E
35.68
Forward P/E
17.67
PEG
1.34
P/S
5.11
P/B
4.23
P/Free Cash Flow
28.07
EPS
1.94
Average EPS Est. Cur. Y
3.47
EPS Next Y. (Est.)
3.91
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
14.44
Relative Volume
1.09
Return on Equity vs Sector %
-15.4
Return on Equity vs Industry %
0.1
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
1533.1
◆
BSX
Healthcare
$69.19
Swing / Pullback
Buy the dip on strong trends
WEAK
RSI
37.6
Range 1M
19.4%
Momentum Growth
Ride accelerating trends
WEAK
EPS Yr
13.3%
EPS NY
13%
52W%
4.2%
Long-Term Value
Quality companies, undervalued
WEAK
🟡 HOLD
+26.7% upside
Upside
+26.7%
Quality
90
MoS
17%
Boston Scientific CorporationSector: Healthcare
Industry: Medical Devices
Employees: 59000
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular. It offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, SpyGlass, single-use scopes used for diagnostic and therapeutic procedures in the pancreaticobiliary system, in endoscopic retrograde cholangiopancreatography procedures, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention products; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, radiofrequency ablation, and intraosseous nerve ablation and deep brain stimulation systems. The company also provides technologies for diagnosing and treating a range of diseases and abnormalities of the heart; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, it offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose and treat forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
BSX
Latest News
—
Caricamento notizie per BSX…
stock quote shares BSX – Boston Scientific Corporation Stock Price stock today
news today BSX – Boston Scientific Corporation stock forecast ,stock prediction 2023 2024 2025
marketwatch BSX – Boston Scientific Corporation yahoo finance google finance
stock history BSX – Boston Scientific Corporation invest stock market
stock prices BSX premarket after hours
ticker BSX fair value insiders trading